Wykorzystanie protokołów Promega na platformie eLabNext ułatwi naukowcom dostęp do najnowszych procedur badawczych

eLabNext, a company within the Eppendorf Group specializing in providing a digital platform for laboratories with laboratory equipment management system (LIMS), electronic laboratory notebooks (ELN), and artificial intelligence (AI) and machine learning (ML) solutions for scientific laboratories, has partnered with Promega Corporation, a global leader in innovative technologies and tools for the life sciences industry. This collaboration aims to enable easy access to Promega’s standard operating procedures (SOPs) through eLabNext’s eLabMarketplace.

Through this partnership, selected protocols related to Promega’s Wizard™ extraction chemistry, GoTaq® reaction mixes, and Glo® bioluminescent assays will be available on the eLabProtocols platform, which allows for the management of protocols and SOPs in electronic form. These protocols can be easily integrated and utilized in eLabJournal, an intuitive and fully customizable ELN provided by eLabNext.

As the industry develops and the demand for laboratory digitalization continues to grow, especially in the context of the inevitable impact of artificial intelligence on biotechnology, we recognize an increasing number of customers who expect easy access to research protocols. We also observe a growing interest in protocols from the fields of cell biology, protein analysis, and other areas. Therefore, it was natural for us to establish a collaboration with Promega. Through this partnership, we will be able to provide more comprehensive digital solutions for our customers. Our main goal is to facilitate the work of scientists, and the integration of Promega’s SOP protocols directly onto our platform will allow them to track the latest protocol updates in real time,” said Zareh Zurabyan, Director of eLabNext in America, Eppendorf Group Company.

“Promega consistently provides digital tools to customers in the field of life science research at universities, pharmaceutical industry, biotechnology, and clinical research. Our collaboration with eLabNext allows for easy adaptation of reagent procedures for specific laboratory studies and facilitates quick sharing with colleagues, thus promoting better collaboration,” said Tom Livelli, Vice President of Life Sciences Products and Services at Promega.

The integration of Promega protocols is another example of the open and customizable functionality of the eLabNext platform through eLabMarketplace.

eLabNext, a company within the Eppendorf Group, has partnered with Promega Corporation, a global leader in innovative life science technologies. This collaboration aims to enable easy access to Promega’s standard operating procedures (SOPs) through the eLabMarketplace platform provided by eLabNext. These protocols will be available on the eLabProtocols platform, which allows for the management of protocols and SOPs in electronic form. These protocols can be easily integrated and utilized in eLabJournal, an intuitive and fully customizable electronic laboratory notebook provided by eLabNext.

As the industry develops and the demand for laboratory digitalization continues to grow, eLabNext has partnered with Promega to provide more comprehensive digital solutions for its customers. The collaboration aims to facilitate the work of scientists, and the integration of Promega’s SOP protocols onto the eLabNext platform will allow them to track the latest protocol updates in real time.

Keywords used in the article: eLabNext, Eppendorf, LIMS, ELN, AI, ML, Promega Corporation, SOP, eLabMarketplace, Wizard™, GoTaq®, Glo®, eLabProtocols, eLabJournal.

Related links:
Eppendorf website
Promega website

The source of the article is from the blog lokale-komercyjne.pl